The MLH1 variant is correlated with the highest risk of developing CRC with a cumulative incidence at 40 years of age of 15.3% in females and 18.9% in males, and a cumulative incidence of endometrial cancer of 1.9% at 40 years [72]. The gene discussed is MLH1; the disease is endometrial cancer.